Moderna said it intends to keep its COVID-19 vaccine on the market for free to consumers, even after the U.S. government stops paying for it, ABC News’ Anne Flaherty reports. "Everyone in the United States will have access to Moderna’s COVID-19 vaccine regardless of their ability to pay," the company said in a statement, according to ABC News. Reference Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MRNA:
- Sanders calls Moderna chief to testify on vaccine price hike plans, WP says
- Model N price target raised to $52 from $45 at Truist
- Catalent price target raised to $82 from $75 at Baird
- Personalis upgraded to Buy at Needham on cost reductions, biopharma potential
- Personalis, Moderna announce new agreement to leverage NeXT Platform